Brief: HBM Healthcare Investments AG Says Co Signs Agreement To Acquire Laboratorios Biopas Group
May 22 (Reuters) - HBM Healthcare Investments AG
HBMN.S :
* SWIXX BIOPHARMA EXPECTS TRANSACTION TO BE IMMEDIATELY
ACCRETIVE
* WILL FINANCE ACQUISITION THROUGH A COMBINATION OF CASH
HELD ON
ITS BALANCE SHEET, BANK LOANS AND EQUITY
* STRATEGIC EXPANSION INTO LATIN AMERICA WITH SIGNING OF AN
AGREEMENT TO ACQUIRE LABORATORIOS BIOPAS GROUP.
Source text for Eikon: ID:nEQ7ctmlya
Further company coverage: HBMN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics